Oncology Today with Dr Neil Love cover image

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Oncology Today with Dr Neil Love

00:00

The Importance of Risk Reduction in Breast Cancer

In stage 2, there's really no debate about a stage 2 patients being offered. Stage 1 is much more unclear to me; I'm having to have that conversation come with a shared decision. Ohio State has had to change practices and reserve the platinum base therapy for those who are curative intent. But we also want to reserve our patients who have been shown to have overall survival intent even if they're not curative.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app